•
QD
QDEL
QuidelOrtho Corporation Common Stock
polygonIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
--
Price Chart
Market Cap
2.00B
Volume
673.39K
52W High
$46.24
52W Low
$19.50
Open
$30.17
Prev Close
$29.42
Day Range
29.83 - 31.43
About QuidelOrtho Corporation Common Stock
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.
Latest News
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire Inc.•Sep 4
Lateral Flow Assays Market to Grow at a CAGR of 7.5% During the Forecast Period (2025 – 2030): Wissen Research
GlobeNewswire Inc.•Aug 28
QuidelOrtho (QDEL) Fiscal Q2 EPS Beats
The Motley Fool•Aug 6
Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment
GlobeNewswire Inc.•Jun 6
Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight
GlobeNewswire Inc.•May 14
Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight
GlobeNewswire Inc.•May 8
Lateral Flow Assay Market Growth Trends and Forecast to 2030 | Global Market Expected to Reach $15.42 Billion by 2030
GlobeNewswire Inc.•Apr 28
Drug Screening Market Size Worth USD 10.34 Billion by 2034 | CAGR of 4.84% from 2025 to 2034
GlobeNewswire Inc.•Apr 17